Literature DB >> 17204237

Association of vasoactive intestinal peptide with polymer-grafted liposomes: structural aspects for pulmonary delivery.

Brigitte Stark1, Paul Debbage, Fritz Andreae, Wilhelm Mosgoeller, Ruth Prassl.   

Abstract

A polymer-grafted liposomal formulation that has the potential to be developed for aerosolic pulmonary delivery of vasoactive intestinal peptide (VIP), a potent vasodilatory neuropeptide, is described. As VIP is prone to rapid proteolytic degradation in the microenvironment of the lung a proper delivery system is required to increase the half-life and bioavailability of the peptide. Here we investigate structural parameters of unilamellar liposomes composed of palmitoyl-oleoyl-phosphatidylcholine, lyso-stearyl-phosphatidylglycerol and distearyl-phosphatidyl-ethanolamine covalently linked to polyethylene glycol 2000, and report on VIP-lipid interaction mechanisms. We found that the cationic VIP is efficiently entrapped by the negatively charged spherical liposomes and becomes converted to an amphipathic alpha-helix. By fluorescence spectroscopy using single Trp-modified VIP we could show that VIP is closely associated to the membrane. Our data suggest that the N-terminal random-coiled domain is embedded in the interfacial headgroup region of the phospholipid bilayer. By doing so, neither the bilayer thickness of the lipid membrane nor the mobility of the phospholipid acyl chains are affected as shown by small angle X-ray scattering and electron spin resonance spectroscopy. Finally, in an ex vivo lung arterial model system we found that liposomal-associated VIP is recognized by its receptors to induce vasodilatory effects with comparable high relaxation efficiency as free VIP but with a significantly retarded dilatation kinetics. In conclusion, we have designed and characterized a liposomal formulation that is qualified to entrap biologically active VIP and displays structural features to be considered for delivery of VIP to the lung.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17204237     DOI: 10.1016/j.bbamem.2006.11.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

Review 1.  Pulmonary applications and toxicity of engineered nanoparticles.

Authors:  Jeffrey W Card; Darryl C Zeldin; James C Bonner; Earle R Nestmann
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-18       Impact factor: 5.464

2.  Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension.

Authors:  Vivek Gupta; Nilesh Gupta; Imam H Shaik; Reza Mehvar; Ivan F McMurtry; Masahiko Oka; Eva Nozik-Grayck; Masanobu Komatsu; Fakhrul Ahsan
Journal:  J Control Release       Date:  2013-01-23       Impact factor: 9.776

3.  Vasoactive intestinal Peptide inhaled agonists: potential role in respiratory therapeutics.

Authors:  Ag Mathioudakis; V Chatzimavridou-Grigoriadou; E Evangelopoulou; Ga Mathioudakis
Journal:  Hippokratia       Date:  2013-01       Impact factor: 0.471

4.  Adiponectin-coated nanoparticles for enhanced imaging of atherosclerotic plaques.

Authors:  Gunter Almer; Karin Wernig; Matthias Saba-Lepek; Samih Haj-Yahya; Johannes Rattenberger; Julian Wagner; Kerstin Gradauer; Daniela Frascione; Georg Pabst; Gerd Leitinger; Harald Mangge; Andreas Zimmer; Ruth Prassl
Journal:  Int J Nanomedicine       Date:  2011-06-21

5.  Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries.

Authors:  Pritesh P Jain; Regina Leber; Chandran Nagaraj; Gerd Leitinger; Bernhard Lehofer; Horst Olschewski; Andrea Olschewski; Ruth Prassl; Leigh M Marsh
Journal:  Int J Nanomedicine       Date:  2014-07-07

Review 6.  Nanomedicine in pulmonary delivery.

Authors:  Heidi M Mansour; Yun-Seok Rhee; Xiao Wu
Journal:  Int J Nanomedicine       Date:  2009-12-29

7.  Interleukin 10-coated nanoparticle systems compared for molecular imaging of atherosclerotic lesions.

Authors:  Gunter Almer; Kelli L Summers; Bernhard Scheicher; Josef Kellner; Ingeborg Stelzer; Gerd Leitinger; Anna Gries; Ruth Prassl; Andreas Zimmer; Harald Mangge
Journal:  Int J Nanomedicine       Date:  2014-09-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.